Save
New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry
ISTH Academy, , 408150
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenters, 408156
Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]
ISTH Academy, Faculty / Presenters, 408155
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis
ISTH Academy, Faculty / Presenters, 408154
Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties
ISTH Academy, Faculty / Presenters, 408153
A regulatory node involving Gα, PLCβ, and RGS proteins modulates platelet reactivity to critical agonists
ISTH Academy, Peisong Ma, 408152
PACSIN2 regulates platelet integrin β1 hemostatic function
ISTH Academy, Herve Falet, 408151
SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia
ISTH Academy, , 408149
Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis
ISTH Academy, Nicola Mutch, 408148
Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry
ISTH Academy, James Douketis, 408147
The TFPIα C-terminal tail is essential for TFPIα-FV-short-protein S complex formation and synergistic enhancement of TFPIα
ISTH Academy, Josefin Ahnstrom, 408146
Design and characterization of novel activated protein C variants for the proteolysis of cytotoxic extracellular histone H3
ISTH Academy, Gerry Nicolaes, 408145
Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States
ISTH Academy, Faculty / Presenters, 408144
Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay
ISTH Academy, Faculty / Presenters, 408143
Short - COVID-19 and Thrombosis: An Update
ISTH Academy, Faculty / Presenters, 408158
COVID-19 and Thrombosis: An Update
ISTH Academy, Faculty / Presenters, 403913
SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis
ISTH Academy, Faculty / Presenters, 405877
From Guidance to Practice: Management of Chemotherapy Induced Thrombocytopenia
ISTH Academy, Gerald Soff, 405878
Molecular basis of inherited protein C deficiency results from genetic variations in the signal peptide and propeptide regions
ISTH Academy, Guomin Shen, 405638
Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody–positive subjects
ISTH Academy, Vittorio Pengo, 405639
Hospital-acquired venous thromboembolism during invasive mechanical ventilation in children: a single-center, retrospective cohort study
ISTH Academy, Faculty / Presenters, 405640
Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model
ISTH Academy, Katsue Suzuki-Inoue, 405641
Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism
ISTH Academy, Charlotte Thålin, 405642
Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study
ISTH Academy, Faculty / Presenters, 405643
Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy
ISTH Academy, Faculty / Presenters, 405644
Quality of life in elderly patients with venous thromboembolism assessed using patient-reported outcome measures
ISTH Academy, , 405645
Is intimate partner abuse underestimated as a precipitating factor for venous thromboembolism in women?
ISTH Academy, Faculty / Presenters, 405646
Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome
ISTH Academy, , 405647
Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling
ISTH Academy, Yanyan Xu, 405648
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy
ISTH Academy, , 405649
Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients
ISTH Academy, , 405650
MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation
ISTH Academy, Frédéric Adam, 405651
APC-PAR1-R46 signaling limits CXCL1 expression during poly IC-induced airway inflammation in mice
ISTH Academy, Silvio Antoniak, 405652
Disseminating information on coagulation (DIC)/bleeding—the hemostatic balance of social media throughout the years
ISTH Academy, Dianne Van Der Wal, 405621
TMEM16E: unscrambling our knowledge about coagulation
ISTH Academy, Rinku Majumder, 405622
Fibrinogen and fibrin: synthesis, structure, and function in health and disease
ISTH Academy, Alisa Wolberg, 405623
Corrigendum to ‘Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children’s Hospital-Acquired Thrombosis Consortium’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139]
ISTH Academy, Faculty / Presenters, 409298
Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?
ISTH Academy, , 409297
Artificial intelligence for venous thromboembolism prophylaxis: Clinician perspectives
ISTH Academy, Rushad Patell, 409296
Western blot and immunohistochemical analysis of mouse tissue factor
ISTH Academy, Faculty / Presenters, 409295
COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms
ISTH Academy, Armando Tripodi, 409294
Factor V Leiden interferes with protein S activity assay
ISTH Academy, Agathe Herb, 409293
The immunogenicity, safety, and efficacy of N8-GP in previously untreated patients with severe hemophilia A: pathfinder6 end-of-trial results
ISTH Academy, Faculty / Presenters, 405636
Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery
ISTH Academy, Faculty / Presenters, 405635
Evaluation of the association of factor XIII at hospital arrival and outcomes in a cohort of severely injured patients
ISTH Academy, Michelle Sholzberg, 405634
DAPT and GPVI: an antiplatelet triple threat
ISTH Academy, Michael Holinstat, 405633
Unraveling the hormonal pathway to megakaryocyte well-being
ISTH Academy, Alessandra Balduini, 405632
MAGT1 mutant platelets unveiled
ISTH Academy, , 405631
Normotensive pulmonary embolism: nothing to sneeze at
ISTH Academy, , 405630
In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study
ISTH Academy, Sandra Le Quellec, 405637
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials
ISTH Academy, Jeffrey Weitz, 405629
Mechanisms regulating heterogeneity of hemostatic gene expression in endothelial cells
ISTH Academy, , 405628
The prothrombotic tendency of metabolic-associated fatty liver disease
ISTH Academy, Faculty / Presenters, 405627
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?
ISTH Academy, Faculty / Presenters, 405626
Role of red blood cells in clinically relevant bleeding tendencies and complications
ISTH Academy, Faculty / Presenters, 405625
Risk stratification of acute pulmonary embolism
ISTH Academy, Faculty / Presenters, 405624
Issue Information
ISTH Academy, Faculty / Presenters, 409264
Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis
ISTH Academy, , 409265
How We Write a Manuscript Discussion
ISTH Academy, Mary Cushman, 409266
Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review
ISTH Academy, Theodore (Ted) Warkentin, 409267
A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults
ISTH Academy, , 409268
Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details
ISTH Academy, Hanny Al-Samkari, 409269
Heavy menstrual bleeding in adolescents: a primary issue in primary care
ISTH Academy, Angela Weyand, 409270
The crux of menopausal hormone therapy: dose, route, and age
ISTH Academy, Lisa Baumann Kreuziger, 409271
Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review
ISTH Academy, , 409272
Investigating patients for bleeding disorders when most of the “usual” ones have been ruled out
ISTH Academy, Johanna Gebhart, 409273
Immune cell–mediated venous thrombus resolution
ISTH Academy, Faculty / Presenters, 409274
What can historical literature on von Willebrand disease teach us?
ISTH Academy, Faculty / Presenters, 409275
D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study
ISTH Academy, Faculty / Presenters, 409276
Venous thromboembolism among physically active young adult females
ISTH Academy, Anna Gurevich-Shapiro, 409277
Posttraumatic stress disorder and posttraumatic stress symptoms among adults with hemophilia A and B
ISTH Academy, Faculty / Presenters, 409278
Antiphospholipid syndrome in rural, remote, and First Nations peoples in the Top End of the Northern Territory, Australia
ISTH Academy, , 409279
Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration
ISTH Academy, Radek Kaczmarek, 409280
Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series
ISTH Academy, Faculty / Presenters, 409281
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates
ISTH Academy, Lucia Stefanini, 409282
Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring
ISTH Academy, François Mullier, 409283
Race, ethnicity, and immune tolerance induction in hemophilia A in the United States
ISTH Academy, Faculty / Presenters, 409284
Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada
ISTH Academy, , 409285
Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes
ISTH Academy, Faculty / Presenters, 409286
The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients
ISTH Academy, Faculty / Presenters, 409287
Factors XI and XII in extracorporeal membrane oxygenation: longitudinal profile in children
ISTH Academy, Faculty / Presenters, 409288
Guiding warfarin self-management in children: development of a warfarin nomogram
ISTH Academy, , 409289
Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
ISTH Academy, , 409290
Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis
ISTH Academy, Faculty / Presenters, 409291
Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time–based clotting time test results in patients treated with emicizumab
ISTH Academy, Flora Peyvandi, 409292
Thromboprophylaxis in Surgery for Teenagers
ISTH Academy, Faculty / Presenters, 405141
DOAC Use in Special Populations: A Focus on Obesity and Bariatric Surgery
ISTH Academy, Faculty / Presenters, 400590
RPTH Research Recap Videos
ISTH Academy, Faculty / Presenters, 405288
Breaking the Silence: Addressing Mental Health in Thrombosis Patients
ISTH Academy, Faculty / Presenters, 393956
A Guide to Writing a Successful Grant
ISTH Academy, Faculty / Presenters, 400589
OC 50.5 Prediction of Inhibitor Development in Previously Untreated Children with Hemophilia a using aMachine-Learning Network and Information Theory Quantifiers: Results from the HEMFIL Cohort Study
ISTH Academy, Faculty / Presenters, 406217
OC 06.1 Trauma Induces Mechanistic and Morphological Changes in Microfluidic Hemostasis
ISTH Academy, Faculty / Presenters, 406216
OC 06.3 Final Analysis Results from a Phase Iii Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)
ISTH Academy, Faculty / Presenters, 406215
OC 53.1 Magnetically Powered Microwheels Enhance Thrombolysis in a Murine Model of Ischemic Stroke
ISTH Academy, Faculty / Presenters, 406214
OC 53.3 Direct Delivery of Plasmin using Clot-Anchoring Thrombin-Responsive Nanoparticles for Targeted Fibrinolytic Therapy
ISTH Academy, Faculty / Presenters, 406213
OC 53.5 Clinical Outcomes in Patients with Acute Pulmonary Embolism Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis
ISTH Academy, Faculty / Presenters, 406212
OC 37.1 Hypoalbuminemia Increases Clot Fibrin Network Density and Impairs Fibrinolysis during Glomerular Proteinuria
ISTH Academy, Faculty / Presenters, 406211
OC 37.4 Plasminogen Retention is Attenuated in Thrombi from Plg-RKT Deficient Mice
ISTH Academy, Faculty / Presenters, 406210
OC 53.4 An siRNA Gene Therapy to Modulate Circulating Plasminogen Activator Inhibitor 1
ISTH Academy, Faculty / Presenters, 406209

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings